These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 3021278
21. Role of glucocorticoids in the modulation of corticotropin-releasing hormone mRNA level by the endogenous benzodiazepine receptor ligand octadecaneuropeptide in rat brain. Givalois L, Li S, Pelletier G. Neuroendocrinology; 1998 Aug; 68(2):98-104. PubMed ID: 9705576 [Abstract] [Full Text] [Related]
22. Structure-activity relationship of peptide fragments derived from DBI (diazepam binding inhibitor), a putative endogenous ligand of benzodiazepine recognition sites. Guidotti A, Santi MR, Berkovich A, Ferrarese C, Costa E. Clin Neuropharmacol; 1986 Aug; 9 Suppl 4():217-9. PubMed ID: 3032426 [No Abstract] [Full Text] [Related]
23. The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. de Mateos-Verchere JG, Leprince J, Tonon MC, Vaudry H, Costentin J. Eur J Pharmacol; 2001 Mar 02; 414(2-3):225-31. PubMed ID: 11239923 [Abstract] [Full Text] [Related]
24. Effect of the triakontatetraneuropeptide (TTN) on corticosteroid secretion by the frog adrenal gland. Lesouhaitier O, Feuilloley M, Vaudry H. J Mol Endocrinol; 1998 Feb 02; 20(1):45-53. PubMed ID: 9513081 [Abstract] [Full Text] [Related]
25. The octadecaneuropeptide-induced response of corticotropin-releasing hormone messenger RNA levels is mediated by GABA(A) receptors and modulated by endogenous steroids. Givalois L, Grinevich V, Li S, Garcia-De-Yebenes E, Pelletier G. Neuroscience; 1998 Jul 02; 85(2):557-67. PubMed ID: 9622252 [Abstract] [Full Text] [Related]
26. Epileptogenic activity of two peptides derived from diazepam binding inhibitor after intrahippocampal injection in rats. Vezzani A, Serafini R, Stasi MA, Samanin R, Ferrarese C. Epilepsia; 1991 Jul 02; 32(5):597-603. PubMed ID: 1655399 [Abstract] [Full Text] [Related]
27. Effect of diazepam binding inhibitor (DBI) on the fluid intake, preference and the taste reactivity in mice. Manabe Y, Toyoda T, Kuroda K, Imaizumi M, Yamamoto T, Fushiki T. Behav Brain Res; 2001 Nov 29; 126(1-2):197-204. PubMed ID: 11704264 [Abstract] [Full Text] [Related]
28. Increased brain content of the endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), following portacaval anastomosis in the rat. Butterworth RF, Tonon MC, Désy L, Giguère JF, Vaudry H, Pelletier G. Peptides; 1991 Nov 29; 12(1):119-25. PubMed ID: 1646996 [Abstract] [Full Text] [Related]
29. Co-localization and co-release of GABA and putative allosteric modulators of GABA receptor. Ferrarese C, Alho H, Guidotti A, Costa E. Neuropharmacology; 1987 Jul 29; 26(7B):1011-8. PubMed ID: 2821427 [Abstract] [Full Text] [Related]
30. Effects of mammalian FMRF-NH2-related peptides and IgG from antiserum against them on aggression and defeat-induced analgesia in mice. Kavaliers M, Yang HY. Peptides; 1991 Jul 29; 12(2):235-9. PubMed ID: 2067975 [Abstract] [Full Text] [Related]
31. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Papadopoulos V, Berkovich A, Krueger KE, Costa E, Guidotti A. Endocrinology; 1991 Sep 29; 129(3):1481-8. PubMed ID: 1651852 [Abstract] [Full Text] [Related]
32. The octadecaneuropeptide exerts an anxiogenic-like action in goldfish. Matsuda K, Wada K, Azuma M, Leprince J, Tonon MC, Sakashita A, Maruyama K, Uchiyama M, Vaudry H. Neuroscience; 2011 May 05; 181():100-8. PubMed ID: 21382452 [Abstract] [Full Text] [Related]
33. A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites. Ferrero P, Guidotti A, Conti-Tronconi B, Costa E. Neuropharmacology; 1984 Nov 05; 23(11):1359-62. PubMed ID: 6098849 [Abstract] [Full Text] [Related]
34. The octadecaneuropeptide ODN prevents 6-hydroxydopamine-induced apoptosis of cerebellar granule neurons through a PKC-MAPK-dependent pathway. Kaddour H, Hamdi Y, Vaudry D, Basille M, Desrues L, Leprince J, Castel H, Vaudry H, Tonon MC, Amri M, Masmoudi-Kouki O. J Neurochem; 2013 May 05; 125(4):620-33. PubMed ID: 23286644 [Abstract] [Full Text] [Related]
35. Neuroprotection with the Endozepine Octadecaneuropeptide, ODN. Masmoudi-Kouki O, Hamdi Y, Ghouili I, Bahdoudi S, Kaddour H, Leprince J, Castel H, Vaudry H, Amri M, Vaudry D, Tonon MC. Curr Pharm Des; 2018 May 05; 24(33):3918-3925. PubMed ID: 30417780 [Abstract] [Full Text] [Related]
36. Behavioral and hormonal effects of centrally injected "anxiogenic" neuropeptides in growing pigs. Parrott RF, Vellucci SV, Goode JA. Pharmacol Biochem Behav; 2000 Jan 01; 65(1):123-9. PubMed ID: 10638645 [Abstract] [Full Text] [Related]
37. In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat. Compère V, Li S, Leprince J, Tonon MC, Vaudry H, Pelletier G. Brain Res Mol Brain Res; 2005 Nov 30; 141(2):156-60. PubMed ID: 16154662 [Abstract] [Full Text] [Related]
38. Modulatory actions of benzodiazepine receptor ligands on agonistic behaviour. Mos J, Olivier B, van der Poel AM. Physiol Behav; 1987 Nov 30; 41(3):265-78. PubMed ID: 2829246 [Abstract] [Full Text] [Related]
39. Cellular and subcellular localization of an octadecaneuropeptide derived from diazepam binding inhibitor: immunohistochemical studies in the rat brain. Alho H, Bovolin P, Jenkins D, Guidotti A, Costa E. J Chem Neuroanat; 1989 Nov 30; 2(6):301-18. PubMed ID: 2482048 [Abstract] [Full Text] [Related]
40. Diazepam binding inhibitor (DBI) reduces testosterone and estradiol levels in vivo. Dong E, Matsumoto K, Watanabe H. Life Sci; 2002 Feb 01; 70(11):1317-23. PubMed ID: 11883709 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]